Ionis Pharmaceuticals | IONS - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Agios Pharmaceuticals USD 18.09M 6.89M 2025-12
Alnylam Pharmaceuticals USD 829.31M 219.56M 2025-12
Arrowhead Research USD 256.47M 228.7M 2025-09
Astellas Pharma JPY 444.26B 12.55B 2026-03
BioCryst Pharmaceuticals USD 153.05M 4.16M 2025-12
BioMarin Pharmaceutical USD 713.01M 81.81M 2025-12
Celltrion KRW 626.11B 81.75B 2025-09
Cspc Pharmaceutical CNY 4.01B 329.18M 2025-12
Deva Holding AS TRY 1.32B 235.77M 2023-09
Divis Laboratories Ltd INR 16.59B 2.05B 2025-12
Esperion Therapeutics USD 140.59M 94.57M 2025-12
Exelixis USD 572.18M 7M 2025-12
Halozyme Therapeutics USD 281.77M 2.41M 2025-09
Ionis Pharmaceuticals USD 195M 40M 2025-12
Kangmei Pharma CNY 270.29M 20.26M 2025-09
Knight Therapeutics CAD 64.72M 8.91M 2025-12
Laboratorios Farma EUR 105.28M 177.08M 2025-06
Medical Developments International AUD 7.35M 7.37M 2025-06
Moderna USD 226M 583M 2025-12
Nektar Therapeutics USD 21.81M 8.06M 2025-12
Neuren Pharmaceuticals AUD 6.69M 6.37M 2025-06
Neurocrine Biosciences USD 787.9M 7M 2025-12
Novartis USD 10.25B 570M 2025-12
Omeros USD -33.16M 18.52M 2024-06
OPKO Health USD 45M 1.89M 2025-12
Organigram Holdings CAD 23.32M 8.52M 2025-12
Pfizer USD 3.54B 7.61B 2025-09
Pharma Mar EUR 86.7M 53.34M 2025-12
PTC Therapeutics USD 148.38M 39.31M 2025-12
Qiagen NV USD 325.27M 19.53M 2025-12
Regeneron Pharmaceuticals USD 3.3B 67M 2025-12
Roche Holding CHF 22.09B 10.04B 2025-12
Sarepta Therapeutics USD 43.55M 204.36M 2025-12
Sartorius EUR 414.5M 18.3M 2026-03
Sino Biopharmaceutical CNY 10.5B 2.53B 2024-12
Tilray USD 57.47M 10.16M 2025-06
Ultragenyx Pharmaceutical USD 178M 46.06M 2025-12
Vertex Pharmaceuticals USD 2.72B 62.4M 2025-12
Zealand Pharma A/S 68.91M 19.35M 2025-12
Zz Pientze Pharmaceu CNY 296.13M 1.1B 2025-06